STAT Plus: In first big randomized trial, Abiomed’s heart pump reduced deaths in heart attack patients
ACC
Coverage of the American College of Cardiology (ACC) conference in Atlanta April 6-8, 2024, plus archived coverage of previous gatherings. ACC.24 offers hundreds of educational sessions and features the release of important clinical research.
Latest
Large trial challenges common practice of prescribing beta blockers after heart attack
STAT Plus: Alnylam’s twice-a-year drug lowered blood pressure when combined with common pills
STAT Plus: Positive trial results set up obesity drug Wegovy for use against heart failure
The astounding 19-year journey to a sea change for heart patients
STAT Plus: Amarin’s Vascepa prevents second and third heart attacks in analysis, fueling debate
STAT Plus: New results show benefits of Esperion’s cholesterol drug — but leave big questions unanswered
STAT Plus: Tiny PhaseBio gets the New England Journal’s spotlight. Can its shares rebound?